C M Olarte-Sánchez, L Valencia Torres, S Body, H J Cassaday, C M Bradshaw, E Szabadi, A J Goudie
Index: J. Psychopharmacol. 26(6) , 857-70, (2012)
Full Text: HTML
The atypical antipsychotic drug clozapine has multiple pharmacological actions, some of which, including 5-hydroxytryptamine (5-HT₂) and histamine (H₁) receptor antagonist effects, are shared by the non-selective 5-HT receptor antagonist cyproheptadine. Atypical antipsychotics have a characteristic profile of action on operant behaviour maintained by progressive ratio schedules, as revealed by Killeen's (1994) mathematical model of schedule controlled behaviour. These drugs increase the values of a parameter that expresses the 'incentive value' of the reinforcer (a) and a parameter that is inversely related to the 'motor capacity' of the organism (δ). This experiment examined the effects of acute treatment with cyproheptadine and clozapine on performance on a progressive ratio schedule of food reinforcement in rats; the effects of a conventional antipsychotic, haloperidol, and two drugs with food intake-enhancing effects, chlordiazepoxide and Δ⁹-tetrahydrocannabinol (THC), were also examined. Cyproheptadine (1, 5 mg kg⁻¹) and clozapine (3.75, 7.5 mg kg⁻¹) increased a and δ. Haloperidol (0.05, 0.1 mg kg⁻¹) reduced a and increased δ. Chlordiazepoxide (3, 10 mg kg⁻¹) increased a but reduced δ. THC (1, 3 mg kg⁻¹) had no effect. Interpretation based on Killeen's (1994) model suggests that cyproheptadine and clozapine enhanced the incentive value of the reinforcer and impaired motor performance. Motor impairment may be due to sedation (possibly reflecting H₁ receptor blockade). Enhancement of incentive value may reflect simultaneous blockade of H₁ and 5-HT₂ receptors, which has been proposed as the mechanism underlying the food intake-enhancing effect of cyproheptadine. In agreement with previous findings, haloperidol impaired motor performance and reduced the incentive value of the reinforcer. Chlordiazepoxide's effect on a is consistent with its food intake-enhancing effect.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
chlordiazepoxide
CAS:58-25-3 |
C16H14ClN3O |
|
Acute tolerance to chlordiazepoxide qualitatively changes th...
2013-01-30 [Eur. J. Pharmacol. 700(1-3) , 159-64, (2013)] |
|
Use of a Sonogel-Carbon electrode modified with bentonite fo...
2012-01-30 [Talanta 89 , 448-54, (2012)] |
|
[Burning sensation in oral cavity--burning mouth syndrome in...
2012-09-30 [Ideggyogy. Sz. 65(9-10) , 295-301, (2012)] |
|
Physiological and behavioural responsivity to stress and anx...
2012-03-17 [Behav. Brain Res. 228(2) , 351-8, (2012)] |
|
A double blind randomised comparison of chlordiazepoxide and...
1983-01-01 [Asian J. Psychiatr. 6(5) , 401-3, (2013)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
